• Parallelization Now Proven Approach in Clinical Trials

    Jan 14 | Clinical Research News | Technology will continue to play a large role in how we conduct trials, but new ways of working will have to be implemented to truly drive change. During the COVID-19 vaccine trials, several new approaches emerged that helped speed the trials and bring the vaccines to market in record time. One such approach is fast-tracking, or parallelization. More
  • 2022 Participant Engagement Award Finalists Announced

    Jan 13 | Clinical Research News | Finalists have been named for the sixth annual Participant Engagement Award. Their work will be highlighted, and a winner will be named at the upcoming 2022 Summit for Clinical Ops Executives (SCOPE), February 7-10 in Orlando, Fla. More
  • Seqster, National Pancreas Foundation, Launch Pancreatic Disease Patient Registry

    Jan 11 | Clinical Research News | Seqster announced today a multi-year partnership with The National Pancreas Foundation, a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, to create the country’s largest, most inclusive pancreatic disease patient registry. The registry uses Seqster technology to connect to any EHR, genomic DNA test, and wearable/remote monitoring device, providing patients with a complete longitudinal health record in real-time. More
  • Bayer Pilots Platform Turning Surplus Clinical Trial Kits Into Donations

    Jan 11 | Clinical Research News | The scalable, not-for-profit technology platform Kits4Life is helping the clinical trial community divert unused and excess study supplies to healthcare organizations around the world that are qualified to accept humanitarian aid. In doing so, the cross-sector initiative has turned the “meaningless act” of destroying the surplus into an impactful gesture of corporate social responsibility and sustainability. More
  • Trendspotting: Decentralized Trials Maintain Momentum, Additional Remote Solutions, AI and Reducing Bias

    Jan 10 | Clinical Research News | We spoke with clinical research leaders to gain insights into expectations for the coming year. They predicted direct-to-patient drug shipments, supply chain digitization, payviders, and AI with wearables and other clinical data, and more. More
  • Multiomics Used To Stratify Multiple Myeloma Patients Into Affinity Groups

    Jan 06 | Clinical Research News | All new multiple myeloma patients being treated at the Tisch Cancer Institute at Mount Sinai are now being assigned to one of 12 subgroups based on shared genetic and molecular features of their disease. The multiple myeloma patient similarity network (MM-PSN) is one of the latest computational modeling tools being used here to translate clinical data into better treatment decision-making in the clinic, and the first to apply multiomics to the stratification of patients with the blood cancer. More
  • Balancing Convenience And Engagement In Decentralized Clinical Trials

    Jan 04 | Clinical Research News | Decentralized clinical trials (DCTs) are a valued option for many would-be study participants as well as a chance to customize the research experience and cater to their needs, according to Ken Getz, founder and chair of the Center for Information & Study on Clinical Research Participation (CISCRP). Findings of CISCRP’s 2021 Perceptions and Insights study indicate interest in DCT approaches is quite high provided they don’t interfere with the quality of patients’ personal relationship with study staff. More
  • Follow the Money: Blood Collection Tech, SPR-Based Proteomics, AAV Gene Therapy Vectors, More

    Dec 28 | Clinical Research News | Technologies for blood collection and testing, immune-competent organoids, flow cytometry for cell therapies, and SPR-based proteomics; funding for Brown Cancer Center More
  • Top Stories of 2021: COVID-19 Vaccines, Decentralized Trials, External Control Arms, Increased Diversity, AI

    Dec 27 | Clinical Research News | Businesses everywhere also looked to leverage the COVID-associated disruptions to the benefit of themselves and society—with new technology to enable and facilitate decentralized clinical trials, arguments for the increased acceptance of external control arms, and the place of AI in clinical data. We also explored practical ideas for increasing clinical trial diversity and reported on a new initiative for better data sharing and standardization in the realm of rare diseases. More
  • Equipping Your Cold Chain Infrastructure for Decentralized Clinical Trials

    Dec 23 | Clinical Research News | Decentralized clinical trials (DCTs) mitigate the burden of transportation, lodging, meals, and dependent care that often pose barriers to study participants. Still, the adoption of DCTs requires a fundamental shift in infrastructure to maintain compliance. This not only includes a shift to the cloud for virtual collaboration between stakeholders and data sharing, but also the elements of infrastructure that cannot be virtualized, such as the cold chain. More
View more articles
 
DXX-Industry-spotlight
DIA

DIA NOW is the source for life science knowledge. Comprehensive and customizable, and backed by DIA's extensive history, global reach, and experience, you'll stay on top of trends and receive up-to-the-minute updates on a wide variety of critical issues in the life sciences arena. Get your one-month free trial today!